HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Symptoms, vascular risk factors and blood-brain barrier function in relation to CT white-matter changes in dementia.

Abstract
The aim was to study the frequently found white-matter changes on computerized tomography (CT) in patients with dementia and to relate these changes to clinical regional brain symptomatology, vascular factors, albumin ratio [indicator of blood-brain barrier (BBB) function] and other CT changes. The study included 85 patients, average age 71 +/- 8, with Alzheimer's disease (n = 56) and vascular dementia (n = 29), who underwent CT (Siemens Somatome DR 1) of the brain. They were inpatients in a psychiatric department specialized in dementia investigations. The degree of CT white-matter changes (absence, mild-moderate, severe) was the basis for the division of the patients into three groups. As the patients without white-matter changes were significantly younger than those with such changes, all statistical analyses were controlled for age. Subcortical symptomatology was significantly more frequent in the group with severe white-matter changes, whereas the reverse was true for parietal symptomatology. Diabetes mellitus, hypertension, ischemic cardiac disease and lacunas were significantly more common in patients with white-matter changes, whereas the frequency of transient ischemic attack/stroke episodes did not differ significantly between the groups. The albumin ratio was significantly higher in the groups with white-matter changes and highest in the group with severe white-matter changes. The findings indicate that white-matter changes in demented patients are at least partially an age- and stroke-independent disease manifestation of the vascular system and is associated with a specific symptom pattern. BBB dysfunction may be the link between the vasculature and the tissue damage.
AuthorsA Wallin, M Sjögren, A Edman, K Blennow, B Regland
JournalEuropean neurology (Eur Neurol) Vol. 44 Issue 4 Pg. 229-35 ( 2000) ISSN: 0014-3022 [Print] Switzerland
PMID11096223 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright 2000 S. Karger AG, Basel
Chemical References
  • Albumins
  • Serum Albumin
Topics
  • Aged
  • Albumins (cerebrospinal fluid)
  • Blood-Brain Barrier (physiology)
  • Brain Infarction (etiology, pathology)
  • Cerebral Arteries (pathology, physiopathology)
  • Cerebrovascular Disorders (complications, pathology, physiopathology)
  • Dementia (etiology, pathology, physiopathology)
  • Disease Progression
  • Female
  • Humans
  • Male
  • Nerve Fibers, Myelinated (pathology)
  • Risk Factors
  • Serum Albumin (metabolism)
  • Telencephalon (blood supply, pathology, physiopathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: